Literature DB >> 31678741

Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.

L Casarrubios1, N Gómez-Cerezo2, S Sánchez-Salcedo2, M J Feito1, M C Serrano3, M Saiz-Pardo4, L Ortega4, D de Pablo4, I Díaz-Güemes5, B Fernández-Tomé5, S Enciso5, F M Sánchez-Margallo5, M T Portolés6, D Arcos2, M Vallet-Regí2.   

Abstract

Silicon-substituted hydroxyapatite (SiHA) macroporous scaffolds have been prepared by robocasting. In order to optimize their bone regeneration properties, we have manufactured these scaffolds presenting different microstructures: nanocrystalline and crystalline. Moreover, their surfaces have been decorated with vascular endothelial growth factor (VEGF) to evaluate the potential coupling between vascularization and bone regeneration. In vitro cell culture tests evidence that nanocrystalline SiHA hinders pre-osteblast proliferation, whereas the presence of VEGF enhances the biological functions of both endothelial cells and pre-osteoblasts. The bone regeneration capability has been evaluated using an osteoporotic sheep model. In vivo observations strongly correlate with in vitro cell culture tests. Those scaffolds made of nanocrystalline SiHA were colonized by fibrous tissue, promoted inflammatory response and fostered osteoclast recruitment. These observations discard nanocystalline SiHA as a suitable material for bone regeneration purposes. On the contrary, those scaffolds made of crystalline SiHA and decorated with VEGF exhibited bone regeneration properties, with high ossification degree, thicker trabeculae and higher presence of osteoblasts and blood vessels. Considering these results, macroporous scaffolds made of SiHA and decorated with VEGF are suitable bone grafts for regeneration purposes, even in adverse pathological scenarios such as osteoporosis. STATEMENT OF SIGNIFICANCE: For the first time, the in vivo behavior of scaffolds made of silicon substituted hydroxyapatites (SiHA) has been evaluated under osteoporosis conditions. In order to optimize the bone regeneration properties of these bioceramics, 3D macroporous scaffolds have been manufactured by robocasting and implanted in osteoporotic sheep. Our experimental design shed light on the important issue of the biological response of nano-sized bioceramics vs highly crystalline bioceramics, as well as on the importance of coupling vascularization and bone growth processes by decorating SiHA scaffolds with vascular endothelial growth factor.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  In vivo test; Macroporous scaffold; Osteoporosis; Silicon substituted hydroxyapatite; VEGF

Year:  2019        PMID: 31678741     DOI: 10.1016/j.actbio.2019.10.033

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  13 in total

Review 1.  Management of bone diseases: looking at scaffold-based strategies for drug delivery.

Authors:  Myriam Bordone; Ana Bettencourt
Journal:  Drug Deliv Transl Res       Date:  2022-07-11       Impact factor: 5.671

Review 2.  Synthesis, Characterization, Functionalization and Bio-Applications of Hydroxyapatite Nanomaterials: An Overview.

Authors:  Muhammad Usman Munir; Sajal Salman; Ayehsa Ihsan; Tilal Elsaman
Journal:  Int J Nanomedicine       Date:  2022-05-02

3.  Effects of Ipriflavone-Loaded Mesoporous Nanospheres on the Differentiation of Endothelial Progenitor Cells and Their Modulation by Macrophages.

Authors:  Laura Casarrubios; Alberto Polo-Montalvo; María Concepción Serrano; María José Feito; María Vallet-Regí; Daniel Arcos; María Teresa Portolés
Journal:  Nanomaterials (Basel)       Date:  2021-04-24       Impact factor: 5.076

4.  Assessment of the Release of Vascular Endothelial Growth Factor from 3D-Printed Poly-ε-Caprolactone/Hydroxyapatite/Calcium Sulfate Scaffold with Enhanced Osteogenic Capacity.

Authors:  Cheng-Yu Chen; Chien-Chang Chen; Chen-Ying Wang; Alvin Kai-Xing Lee; Chun-Liang Yeh; Chun-Pin Lin
Journal:  Polymers (Basel)       Date:  2020-06-29       Impact factor: 4.329

5.  The Influence of Nanometals, Dispersed in the Electrophoretic Nanohydroxyapatite Coatings on the Ti13Zr13Nb Alloy, on Their Morphology and Mechanical Properties.

Authors:  Michał Bartmański; Łukasz Pawłowski; Aleksandra Mielewczyk-Gryń; Gabriel Strugała; Krzysztof Rokosz; Sofia Gaiaschi; Patrick Chapon; Steinar Raaen; Andrzej Zieliński
Journal:  Materials (Basel)       Date:  2021-03-26       Impact factor: 3.623

Review 6.  Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?

Authors:  Christian Horst Tonk; Sarah Hani Shoushrah; Patrick Babczyk; Basma El Khaldi-Hansen; Margit Schulze; Monika Herten; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

7.  Osteogenic Induction with Silicon Hydroxyapatite Using Modified Autologous Adipose Tissue-Derived Stromal Vascular Fraction: In Vitro and Qualitative Histomorphometric Analysis.

Authors:  Muhammad Marghoob Khan; Shadab Ahmed Butt; Aqif Anwar Chaudhry; Amir Rashid; Kashif Ijaz; Asifa Majeed; Hashmat Gul
Journal:  Materials (Basel)       Date:  2022-02-28       Impact factor: 3.623

Review 8.  Inorganic Nanoparticles in Bone Healing Applications.

Authors:  Alexandra-Cristina Burdușel; Oana Gherasim; Ecaterina Andronescu; Alexandru Mihai Grumezescu; Anton Ficai
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

9.  Silicate/zinc-substituted strontium apatite coating improves the osteoinductive properties of β-tricalcium phosphate bone graft substitute.

Authors:  Hironori Sugimoto; Yusuke Inagaki; Akira Furukawa; Tsutomu Kira; Sachiko Kawasaki; Yoshinobu Uchihara; Manabu Akahane; Yasuhito Tanaka
Journal:  BMC Musculoskelet Disord       Date:  2021-08-09       Impact factor: 2.362

10.  3D Printed SiOC(N) Ceramic Scaffolds for Bone Tissue Regeneration: Improved Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Yuejiao Yang; Apoorv Kulkarni; Gian Domenico Soraru; Joshua M Pearce; Antonella Motta
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.